NOTE – This is an archive post from the NPC and has not been updated since first publication. Therefore, some hyperlinks may no longer be working. 22 September 2009 The FDA is reviewing the safety information for Orlistat following reports of serious liver injury. However, no definite association between liver injury and orlistat has been […]
Category Archives: Patient safety and risk
NPC Archive Item: September Drug Safety Update from MHRA/CHM
NOTE – This is an archive post from the NPC and has not been updated since first publication. Therefore, some hyperlinks may no longer be working. The Drug Safety Update is an NHS Evidence accredited provider 11th September 2009 New data show that insulin glargine is not associated with an increase in cancer (07/08/12) Since […]
NPC Archive Item: August Drug Safety Update from MHRA/CHM
NOTE – This is an archive post from the NPC and has not been updated since first publication. Therefore, some hyperlinks may no longer be working. The Drug Safety Update is an NHS Evidence accredited provider 8th September 2009 The MHRA and CHM have published the August edition of Drug Safety Update. This issue gives […]
NPC Archive Item: NPC Podcast – 28th July 2009
NOTE – This is an archive post from the NPC and has not been updated since first publication. Therefore, some hyperlinks may no longer be working. Carl Dawood talks to Dr Christine Johnson, Primary Care Adviser for the National Patient Safety Agency (NPSA), about the work of the NPSA and specifically the Seven Steps to […]
NPC Archive Item: July Drug Safety Update from MHRA/CHM
NOTE – This is an archive post from the NPC and has not been updated since first publication. Therefore, some hyperlinks may no longer be working. The Drug Safety Update is an NHS Evidence accredited provider 7th July 2009 The MHRA and CHM have published the July edition of Drug Safety Update. This issue gives […]
NPC Archive Item: Swine flu: reporting suspected adverse reactions to oseltamivir▼, zanamivir▼ and future vaccines
NOTE – This is an archive post from the NPC and has not been updated since first publication. Therefore, some hyperlinks may no longer be working. 7th July 2009 The MHRA has set up the Swine Flu ADR Portal to monitor the safety of oseltamivir▼ (Tamiflu) and zanamivir▼ (Relenza) as their use increases during the […]
NPC Archive Item: NPSA Review of patient safety for children and young people
NOTE – This is an archive post from the NPC and has not been updated since first publication. Therefore, some hyperlinks may no longer be working. Published in June 2009 by the National Patient Safety Agency (NPSA), the review of patient safety for children and young people highlights some of the patient safety issues for […]
NPC Archive Item: June Drug Safety Update from MHRA/CHM
NOTE – This is an archive post from the NPC and has not been updated since first publication. Therefore, some hyperlinks may no longer be working. The Drug Safety Update is an NHS Evidence accredited provider 11th June 2009 The MHRA and CHM have published the June edition of Drug Safety Update. This issue gives […]
NPC Archive Item: EMEA statement on possible interaction between clopidogrel and proton pump inhibitors
NOTE – This is an archive post from the NPC and has not been updated since first publication. Therefore, some hyperlinks may no longer be working. 4th June 2009 Concomitant use of proton pump inhibitors (PPIs) and clopidogrel is not advisable unless absolutely necessary, the EU Committee for Medicinal products for Human Use (CHMP) and […]
NPC Archive Item: The Contribution of Pharmacy to Making Britain a Safer Place to Take Medicines
NOTE – This is an archive post from the NPC and has not been updated since first publication. Therefore, some hyperlinks may no longer be working. 20th March 2009 Introduction: In the publication ‘The Contribution of Pharmacy to Making Britain a Safer Place to Take Medicines’, the Royal Pharmaceutical Society of Great Britain (RPSGB) revisits […]